Extend Podcast with Darshan Shah, MD

152. Nick Norwitz: Cholesterol Myths, Insulin Resistance, and the Real Drivers of Heart Disease

Apr 2, 2026
Nick Norwitz, physician-scientist (PhD Oxford, MD Harvard) and metabolic health researcher. He tackles cholesterol myths, contrasts LDL and ApoB, and spotlights insulin resistance as a stronger predictor of heart disease. They cover statins’ broader effects, imaging to personalize risk, and alternative therapies and diagnostics in short, sharp conversations.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ADVICE

Use Coronary Imaging To Personalize Treatment

  • Use cardiac imaging to personalize statin decisions rather than relying on LDL alone.
  • Norwitz suggests coronary artery calcium or CT angiography can reveal plaque burden and may justify avoiding statins even with very high LDL.
INSIGHT

Null Results Don't Prove Absence Of Harm

  • Meta-analyses reporting 'no side effects' can mask trends toward harm that don't cross statistical thresholds.
  • Norwitz critiques a Lancet statin meta-analysis that found many non-significant trends and presented results in confusing plots, cautioning against overconfident headlines.
ADVICE

Give CoQ10 And Consider TUDCA With Statins

  • Supplement CoQ10 and consider TUDCA if you take statins to counter mitochondrial and GLP‑1/bile acid effects.
  • Norwitz recommends a phytosome CoQ10 for absorption and TUDCA/UDCA as potentially helpful adjuncts.
Get the Snipd Podcast app to discover more snips from this episode
Get the app